152 related articles for article (PubMed ID: 37616114)
1. Seroprevalence, seroconversion and seroreversion of
Böhm S; Woudenberg T; Stark K; Böhmer MM; Katz K; Kuhnert R; Schlaud M; Wilking H; Fingerle V
Euro Surveill; 2023 Aug; 28(34):. PubMed ID: 37616114
[TBL] [Abstract][Full Text] [Related]
2. Dynamics of
Woudenberg T; Böhm S; Böhmer M; Katz K; Willrich N; Stark K; Kuhnert R; Fingerle V; Wilking H
Microorganisms; 2020 Nov; 8(12):. PubMed ID: 33255673
[TBL] [Abstract][Full Text] [Related]
3. Seroprevalence for
Septfons A; Rigaud E; Bénézet L; Velay A; Zilliox L; Baldinger L; Gonzalez G; Figoni J; de Valk H; Deffontaines G; Desenclos JC; Jaulhac B
Euro Surveill; 2023 Aug; 28(32):. PubMed ID: 37561054
[TBL] [Abstract][Full Text] [Related]
4. Seropositivity of Lyme borreliosis and associated risk factors: a population-based study in Children and Adolescents in Germany (KiGGS).
Dehnert M; Fingerle V; Klier C; Talaska T; Schlaud M; Krause G; Wilking H; Poggensee G
PLoS One; 2012; 7(8):e41321. PubMed ID: 22905101
[TBL] [Abstract][Full Text] [Related]
5. [Seroprevalence of Borrelia burgdorferi and tick-borne encephalitis virus in a rural area of Samsun, Turkey].
Aslan Başbulut E; Gözalan A; Sönmez C; Cöplü N; Körhasan B; Esen B; Akın L; Ertek M
Mikrobiyol Bul; 2012 Apr; 46(2):247-56. PubMed ID: 22639313
[TBL] [Abstract][Full Text] [Related]
6. Regional seropositivity for Borrelia burgdorferi and associated risk factors: findings from the Rhineland Study, Germany.
Coors A; Hassenstein MJ; Krause G; Kerrinnes T; Harries M; Breteler MMB; Castell S
Parasit Vectors; 2022 Jul; 15(1):241. PubMed ID: 35786209
[TBL] [Abstract][Full Text] [Related]
7. Population-based Borrelia burgdorferi sensu lato seroprevalence and associated risk factors in Finland.
van Beek J; Sajanti E; Helve O; Ollgren J; Virtanen MJ; Rissanen H; Lyytikäinen O; Hytönen J; Sane J
Ticks Tick Borne Dis; 2018 Feb; 9(2):275-280. PubMed ID: 29153461
[TBL] [Abstract][Full Text] [Related]
8. Seroprevalence of Borrelia IgG antibodies among young Swedish children in relation to reported tick bites, symptoms and previous treatment for Lyme borreliosis: a population-based survey.
Skogman BH; Ekerfelt C; Ludvigsson J; Forsberg P
Arch Dis Child; 2010 Dec; 95(12):1013-6. PubMed ID: 20702388
[TBL] [Abstract][Full Text] [Related]
9. Seroprevalence of Borrelia IgG antibodies among individuals from Eastern Slovakia.
Houžvičková A; Dorko E; Rimárová K; Diabelková J; Drabiščák E
Cent Eur J Public Health; 2022 Jun; 30(Supplement):S16-S21. PubMed ID: 35841220
[TBL] [Abstract][Full Text] [Related]
10. The diagnostic value of serum Borrelia burgdorferi antibodies and seroconversion after Lyme neuroborreliosis, a nationwide observational study.
Tetens MM; Dessau R; Ellermann-Eriksen S; Andersen NS; Jørgensen CS; Østergaard C; Bodilsen J; Damgaard DF; Bangsborg J; Nielsen AC; Møller JK; Omland LH; Obel N; Lebech AM
Clin Microbiol Infect; 2022 Nov; 28(11):1500.e1-1500.e6. PubMed ID: 35709901
[TBL] [Abstract][Full Text] [Related]
11. Seroprevalence of antibodies against Borrelia burgdorferi sensu lato in healthy blood donors in Romania: an update.
Kalmár Z; Briciu V; Coroian M; Flonta M; Rădulescu AL; Topan A; Mihalca AD; Lupșe M
Parasit Vectors; 2021 Dec; 14(1):596. PubMed ID: 34863277
[TBL] [Abstract][Full Text] [Related]
12. Assessing the risk of human granulocytic anaplasmosis and lyme borreliosis after a tick bite in Bavaria, Germany.
von Wissmann B; Hautmann W; Sing A; Hizo-Teufel C; Fingerle V
Int J Med Microbiol; 2015 Oct; 305(7):736-41. PubMed ID: 26338146
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal study of Borrelia burgdorferi infection in New Jersey outdoor workers, 1988-1991.
Schwartz BS; Goldstein MD; Childs JE
Am J Epidemiol; 1994 Mar; 139(5):504-12. PubMed ID: 8154474
[TBL] [Abstract][Full Text] [Related]
14. Seroprevalence of Borrelia burgdorferi in Belgian forestry workers and associated risk factors.
De Keukeleire M; Robert A; Luyasu V; Kabamba B; Vanwambeke SO
Parasit Vectors; 2018 May; 11(1):277. PubMed ID: 29716647
[TBL] [Abstract][Full Text] [Related]
15. Seroprevalence and risk factors of Borrelia burgdorferi sensu lato and Rickettsia species infection in humans in Mongolia, 2016-2020.
Ganbold D; Uudus B; Nyamdavaa N; Chultemsuren Y; Zagd A; Tangad M; Bayarmaa A; Lkunrev R; Baasandagva U; Nyamdorj T; Narankhajid M
PLoS One; 2023; 18(8):e0289274. PubMed ID: 37552652
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and incidence of antibodies to Borrelia burgdorferi and to tick-borne encephalitis virus in agricultural and forestry workers from Tuscany, Italy.
Tomao P; Ciceroni L; D'Ovidio MC; De Rosa M; Vonesch N; Iavicoli S; Signorini S; Ciarrocchi S; Ciufolini MG; Fiorentini C; Papaleo B
Eur J Clin Microbiol Infect Dis; 2005 Jul; 24(7):457-63. PubMed ID: 15948001
[TBL] [Abstract][Full Text] [Related]
17. The value of seroprevalence data as surveillance tool for Lyme borreliosis in the general population: the experience of Belgium.
Lernout T; Kabamba-Mukadi B; Saegeman V; Tré-Hardy M; de Laveleye M; Asikainen T; Dessau RB; Quoilin S; Litzroth A
BMC Public Health; 2019 May; 19(1):597. PubMed ID: 31101034
[TBL] [Abstract][Full Text] [Related]
18. Borrelia burgdorferi sensu lato seroconversion after intravenous immunoglobulin treatment: A cohort study.
Lucke IM; Vrijlandt A; Lim J; van der Kooi AJ; van Schaik IN; Zaaijer HL; Hovius JW; Eftimov F
Eur J Neurol; 2021 Jul; 28(7):2383-2387. PubMed ID: 33817927
[TBL] [Abstract][Full Text] [Related]
19. Seroprevalence of Lyme borreliosis in Finland 50 years ago.
Cuellar J; Dub T; Sane J; Hytönen J
Clin Microbiol Infect; 2020 May; 26(5):632-636. PubMed ID: 31622667
[TBL] [Abstract][Full Text] [Related]
20. Global seroprevalence and sociodemographic characteristics of
Dong Y; Zhou G; Cao W; Xu X; Zhang Y; Ji Z; Yang J; Chen J; Liu M; Fan Y; Kong J; Wen S; Li B; Yue P; Liu A; Bao F
BMJ Glob Health; 2022 Jun; 7(6):. PubMed ID: 35697507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
